Wikidata

(Q65474251)

English

A Study of the Safety and Efficacy of Ustekinumab (CNTO 1275) in Patients With Moderate to Severe Psoriasis

clinical trial

In more languages

Statements

title
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial Evaluating the Efficacy and Safety of CNTO 1275 in the Treatment of Subjects With Moderate to Severe Plaque-type Psoriasis. (English)
0 references
country
Austria
0 references
Canada
0 references
France
0 references
Germany
0 references
Switzerland
0 references
United Kingdom
0 references
start time
May 2005
0 references
end time
December 2006
0 references
number of participants
1,230
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q65474251&oldid=1858476645"